AUG 18, 2026 · PHASE 2 TRIAL
Romiplostim N01 for Injection for Secondary Prophylaxis of CIT in Breast Cancer
ClinicalTrials.gov
This is a Phase 2 trial registration with no reported results; the study is not yet recruiting and contains only planned design and endpoints.
Reported
Planned enrollment53
PhasePhase 2
Primary outcome measureProportion of patients achieving response,…